Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Edwards.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Asklepios, Ausper, Clene, Inovio, Novo Nordisk.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Oticon.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Almirall, Arcutis, Curium, Longeveron, Pharmassêtx.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Immersivetouch, Inspira .

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arcutis, Biocryst, Elevar, Genentech, HLB, Mesoblast, Obsidian, Zevra.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Remsleep.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adicet, Alteogen, Defence, Mirium, Outlook, Sellas.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cordis, Curonix, Forma, Mainstay, Orthofix, Roche, Tactile Systems Technology.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alteogen, Full-Life Technologies, Gyre, Hutchmed, Mesoblast.